New anesthesia cocktail aims to get kidney surgery patients home faster
NCT ID NCT07558226
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study compares a combination of anesthesia methods (multimodal) to standard anesthesia for people having robotic kidney surgery for cancer. The goal is to see if the special approach helps patients recover more quickly, have less pain, and go home sooner. About 80 adults will take part, and the study will measure hospital stay length and pain levels after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Nov 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients ≥18 years. * Indication for elective oncological robotic partial or radical nephrectomy. * ASA classification I-III. * Candidates for short-stay surgery according to institutional protocol. * Signed informed consent. Exclusion Criteria: * Chronic opioid use. Defined as continuous opioid use during the 3 months prior to surgery * Uncontrolled chronic pain. Defined as chronic pain not adequately controlled with usual treatment during the 3 months prior to surgery. * Contraindications to NSAIDs, regional anesthesia, or drugs of the multimodal protocol. * Advanced renal failure (GFR \<30 ml/min) at the preanesthetic visit.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anesthesia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fundacio Puigvert
RECRUITINGBarcelona, BARCELONA, 08025, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two drugs shrink kidney tumors and their vein clots before surgery?
- Blood test aims to catch Cancer's return earlier
- Can a gentler anesthesia cocktail protect a child's developing brain?
- Which monitor reads a Child's pain best during surgery?
- Propofol vs. inhaled anesthesia: which one spares your recovery?
- Can a new drug target Hard-to-Treat kidney and ovarian cancers?